Researchers evaluated previous work conducting controlled trials of patients undergoing antibiotic therapy.
Numinus to Host Q3 2023 Results Conference Call on July 17, 2023 | Psychedelic Invest
Numinus Wellness Inc. (TSX: NUMI / OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, will release its financial results